| Literature DB >> 30208152 |
Vitor Moraes Rocha1, Heloisa Amaral Gaspar2, Claudio Flauzino de Oliveira2.
Abstract
OBJECTIVE: To assess the ten-year risk of hip and osteoporotic fracture in home care patients using the FRAX® tool.Entities:
Mesh:
Year: 2018 PMID: 30208152 PMCID: PMC6122886 DOI: 10.1590/S1679-45082018AO4236
Source DB: PubMed Journal: Einstein (Sao Paulo) ISSN: 1679-4508
Demographic variables
| Variable | Patients (n) | Age in years (mean±standard deviation) |
|---|---|---|
| Sex | ||
| Female | 131 | 71.5±13 |
| Male | 91 | 66.9±14.8 |
| Age range, years | ||
| 40-50 | 27 | 45.5±2.9 |
| 51-60 | 40 | 55.15±2.6 |
| 61-70 | 35 | 64.6±2.9 |
| 71-80 | 52 | 75.9±2.9 |
| >80 | 68 | 85.5±2.5 |
| BMI | ||
| <18,5 | 9 | 69±14.8 |
| 18.5-24.9 | 111 | 67.7±15.1 |
| 25-29.9 | 59 | 71.9±15 |
| 30-34.9 | 29 | 71.5±11.1 |
| >35 | 14 | 71.6±11.3 |
| Home care program | ||
| Home care | 96 | 70.7±14.7 |
| Home admission | 126 | 68.8±14.2 |
| Total | 222 | 69.7±١٤.٤ |
BMI: body mass index.
Figure 1Diagnoses according to the International Statistical Classification of Diseases (ICD)
Risk of osteoporotic and hip fracture within 10 years
| n | Osteoporotic fracture | Hip fracture | |||
|---|---|---|---|---|---|
|
|
| ||||
| Mean and standard deviation (%) | p value | Mean and standard deviation (%) | p value | ||
| Sex | |||||
| Female | 131 | 7.9±5.2 | 3.7±3.4 | ||
| Male | 91 | 3.7±2.2 | <0.001* | 1.7±1.8 | <0.0001* |
| Age group | |||||
| Adult | 66 | 2.6±1.1 | 0.3±0.3 | ||
| Elderly | 156 | 7.7±4.8 | <0.001* | 3.9±3 | <0.001* |
| Age group, years | |||||
| 40-50 | 27 | 2.4±1 | 0.2±0.3 | ||
| 51-60 | 40 | 2.7±1.2 | 0.4±0.3 | ||
| 61-70 | 35 | 3.3±1.7 | 1±0.9 | ||
| 71-80 | 52 | 6.4±3.2 | 3.3±2.4 | ||
| >80 | 68 | 11.1±4.6 | <0.001† | 6±2.7 | <0.001† |
| BMI | |||||
| <18.5 | 9 | 6.5±3.9 | 4.1 ±3.7 | ||
| 18.5-24.9 | 111 | 6.5±5.2 | 3.2 ±3.5 | ||
| 25-29.9 | 59 | 6.6±4.6 | 2.8 ±2.5 | ||
| 30-34.9 | 29 | 5.4±3.5 | 2 ±1.2 | ||
| >35 | 14 | 3.9±2.7 | 0.2711† | 1.2 ±1.2 | 0.0464† |
| Type of care | |||||
| Home care | 96 | 5.8±4.6 | 2.7±2.8 | ||
| Home admission | 126 | 6.5±4.8 | 0.1936* | 3±3.2 | 0.3030* |
| Previous fracture and or osteoporosis | |||||
| Absent or unknown | 198 | 5.9±4.4 | 2.8±2.9 | ||
| Present | 24 | 8.6±6.5 | 0.0114* | 3.6±4.2 | 0.3628* |
| Use of steroids‡ | |||||
| Absent | 204 | 6.2±4.7 | 2.9±3 | ||
| Present | 18 | 6.8±4.6 | 0.2543* | 3±3.7 | 0.7642* |
| Total | 222 | 6.2±4.7 | 2.9±3 | ||
* Mann-Whitney teste; † analysis of variance; ‡ steroids for over 3 month, dose of 5mg/day prednisone or equivalent.
Figure 2Estimated 10-year risk of osteoporotic fracture according to age and sex (FRAX® tool)
Figure 3Estimated 10-year risk of hip fracture according to age and sex (FRAX® tool)
Risk of hip and major osteoporotic fracture, per age group, in the present study as compared to the study by Looker et al.( )
| Type of fracture | Present study | Looker et al.(
|
|---|---|---|
| Hip, years | ||
| 40-50 | 0.24 | 0.1 |
| 51-60 | 0.39 | 0.38 |
| 61-70 | 0.99 | 0.86 |
| 71-80 | 2.65 | 2.41 |
| >80 | 5.6 | * |
| Major osteoporotic fracture, years | ||
| 40-50 | 2.39 | 2.59 |
| 51-60 | 1.73 | 5.54 |
| 61-70 | 3.34 | 7.77 |
| 71-80 | 6.15 | 9.57 |
| >80 | 12 | 11.35 |
* Imprecise data due to standard deviation > 50%.